Last reviewed · How we verify

NCT03937310

NGS for Non-unions

Status unknown Last updated 3 May 2019
What this trial tests

trial testing Next-generation sequencing of swabs collected during surgery in Nonunion of Fracture in 120 participants. Status unknown.

Timeline
3 January 2019
Primary endpoint
3 January 2022
3 February 2022

Quick facts

Lead sponsorRothman Institute Orthopaedics
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment120
Start date3 January 2019
Primary completion3 January 2022
Estimated completion3 February 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Rothman Institute Orthopaedics

Who can join

18 and older, any sex, with Nonunion of Fracture. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate the role of genetic testing to look for possible infection as a cause for failure of non-healing fractures. The study aims to compare the results of genetic testing known as NGS to standardized clinical laboratory tests for diagnosing infections to see if NGS may be a better diagnostic tool.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Nonunion of Fracture

Currently open trials in the same condition.

Other Rothman Institute Orthopaedics trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03937310.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing